Moderna, Inc.
(NASDAQ : MRNA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -4.45%160.070.0%$1484.90m
NVAXNovavax, Inc. -6.32%84.6578.2%$581.13m
AMGNAmgen, Inc. -0.52%227.721.4%$512.75m
BIIBBiogen, Inc. -2.39%220.521.8%$496.77m
GILDGilead Sciences, Inc. 1.03%68.511.0%$492.03m
BNTXBioNTech SE -5.77%147.500.0%$413.51m
REGNRegeneron Pharmaceuticals, Inc. 1.14%621.402.7%$402.73m
ILMNIllumina, Inc. -3.81%365.943.3%$378.85m
VRTXVertex Pharmaceuticals, Inc. -0.23%228.081.9%$340.95m
SNSSSunesis Pharmaceuticals, Inc. -3.99%2.650.7%$185.24m
EXASEXACT Sciences Corp. -2.63%74.0317.9%$168.66m
ARNAArena Pharmaceuticals, Inc. -0.58%90.4813.7%$131.37m
INCYIncyte Corp. 0.04%74.792.4%$130.18m
ALNYAlnylam Pharmaceuticals, Inc. -1.37%136.418.2%$125.00m
BMRNBioMarin Pharmaceutical, Inc. 0.24%84.654.2%$103.18m

Company Profile

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.